Here, we investigated whether deep sequencing of KRAS codons 12, 13 and 61 in cfDNA from plasma samples from a large series of more than 400 pancreatic cancer cases and 500 controls could represent a comprehensive assay for sensitive and specific detection of pancreatic cancer. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.